Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and ...

Six men are facing drug and weapon charges following a Thursday incident in Timmonsville, according to the Florence County ...

Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Sarepta said it accepts the CHMP decision on Elevidys, while partner Roche said it will continue working with the EMA.

A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...

Abby Long is stepping down as executive director of the Kingdom Trail Association after eight years and will take on a new ...

Most Americans encounter the Federal Trade Commission only if they’ve been scammed: It handles identity theft, fraud, and ...

Adicet Bio has dosed the first systemic sclerosis (SSc) subject in the Phase I trial’s second cohort evaluating ADI-001.

In the last week, the United States market has been flat, but over the past 12 months, it has risen by 18%, with earnings expected to grow by 15% per annum in the coming years. In this context of ...

MeMed has developed MeMed BV Flex, a rapid infection differentiation test that distinguishes between bacterial and viral infections.

Nishijinori, the intricate weaving for kimonos that dates back more than a thousand years in Japan's ancient capital of Kyoto ...